Papers

5

Total Citations

102

H-Index

4

About

Dr. Michael Bouvet is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for esophageal and gastric cancers. He is best known for pioneering robotic-assisted transhiatal esophagectomy (RATE), demonstrating its safety and efficacy for patients with esophageal cancer, even after neoadjuvant chemoradiation. His work has fundamentally shaped the field, culminating in his role as lead author of the first international consensus statement on robot-assisted minimally invasive esophagectomy (RAMIE), a landmark paper with 26 citations that established global standards. Dr. Bouvet also introduced an innovative approach to pyloric drainage—intraoperative endoscopic Botox injection during total esophagectomy—which prevents the need for more invasive pyloromyotomy or dilatation (27 citations). His comparative studies on minimally invasive versus open gastrectomy for gastric adenocarcinoma have further informed Western surgical practice. With his most-cited papers accumulating over 100 citations, Dr. Bouvet’s contributions have not only improved patient outcomes by reducing morbidity but have also set new benchmarks for robotic esophageal surgery worldwide.

Research Focus

Key Achievements

4
H-Index
5
Papers
102
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of Robotic-Assisted Transhiatal Esophagectomy for Esophageal Cancer After Neoadjuvant Chemoradiation
33 citations · 2014
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: University of California San Diego, Nanchang University, UC San Diego Health System

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago